- Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
-
Liang LY, Wong VWS, Wong GLH, Yip TCF
- KMID: 2538207
- Clin Mol Hepatol.
- 2023 Jan;29(1):113-117.
- doi: 10.3350/cmh.2022.0333
-
- CITED
-
- Close
- SHARE
-
- Close
- Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
-
Yip TCF, Wong GLH, Wong VWS
- KMID: 2514767
- Clin Mol Hepatol.
- 2021 Apr;27(2):273-277.
- doi: 10.3350/cmh.2021.0019
-
- CITED
-
- Close
- SHARE
-
- Close
- Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”
-
Yiu DCY, Lin H, Wong VWS, Wong GLH, Liu K, Yip TCF
- KMID: 2560099
- Clin Mol Hepatol.
- 2024 Oct;30(4):970-973.
- doi: 10.3350/cmh.2024.0280
-
- CITED
-
- Close
- SHARE
-
- Close
- Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma: Editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
-
Dai J, Lai JCT, Wong GLH, Yip TCF
- KMID: 2560074
- Clin Mol Hepatol.
- 2024 Oct;30(4):698-701.
- doi: 10.3350/cmh.2024.0327
-
- CITED
-
- Close
- SHARE
-
- Close
- Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
-
Yip TCF, Lyu F, Lin H, Li G, Yuen PC, Wong VWS, Wong GLH
- KMID: 2539799
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S171-S183.
- doi: 10.3350/cmh.2022.0426
Inflammation is the key driver of liver fibrosis progression in non-alcoholic fatty liver disease (NAFLD). Unfortunately, it is often challenging to assess inflammation in NAFLD due to its dynamic nature... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
-
Liang LY, Lee HW, Wong VWS, Yip TCF, Tse YK, Hui VWK, Lui GCY, Chan HLY, Wong GLH
- KMID: 2517633
- Clin Mol Hepatol.
- 2021 Jul;27(3):499-509.
- doi: 10.3350/cmh.2020.0333
Background/Aims: Serum fibrosis scores comprised of common laboratory tests have high utility to assess severity of liver fibrosis. We aimed to derive and validate a hepatocellular carcinoma (HCC) risk score... -
- CITED
-
- Close
- SHARE
-
- Close
- U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
-
Lin H, Wong GLH, Zhang X, Yip TCF, Liu K, Tse YK, Hui VWK, Lai JCT, Chan HLY, Wong VWS
- KMID: 2523873
- Clin Mol Hepatol.
- 2022 Jan;28(1):77-90.
- doi: 10.3350/cmh.2021.0188
Background/Aims: We aimed to determine the association between blood urea level and incident cirrhosis, hepatic decompensation, and hepatocellular carcinoma in chronic liver disease (CLD) patients. Methods: The association between blood urea... -
- CITED
-
- Close
- SHARE
-
- Close
